Tenaya Therapeutics analyst ratings
Tenaya Therapeutics analyst ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/15/2022 | 364.68% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
05/17/2022 | 178.81% | Morgan Stanley | $19 → $15 | Maintains | Overweight |
08/24/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
08/24/2021 | 476.21% | Morgan Stanley | → $31 | Initiates Coverage On | → Overweight |
08/24/2021 | 587.73% | Chardan Capital | → $37 | Initiates Coverage On | → Buy |
08/24/2021 | 643.49% | Piper Sandler | → $40 | Initiates Coverage On | → Overweight |
Tenaya Therapeutics Questions & Answers
The latest price target for Tenaya Therapeutics (NASDAQ: TNYA) was reported by HC Wainwright & Co. on June 15, 2022. The analyst firm set a price target for $25.00 expecting TNYA to rise to within 12 months (a possible 364.68% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Tenaya Therapeutics (NASDAQ: TNYA) was provided by HC Wainwright & Co., and Tenaya Therapeutics initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on June 15, 2022 so you should expect the next rating to be made available sometime around June 15, 2023.
While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a initiated with a price target of $0.00 to $25.00. The current price Tenaya Therapeutics (TNYA) is trading at is $5.38, which is within the analyst's predicted range.
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
06/15/2022 | 364.68% | HC Wainwright & Co. | → $25 | Initiates Coverage On | → Buy |
05/17/2022 | 178.81% | Morgan Stanley | $19 → $15 | Maintains | Overweight |
08/24/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
08/24/2021 | 476.21% | Morgan Stanley | → $31 | Initiates Coverage On | → Overweight |
08/24/2021 | 587.73% | Chardan Capital | → $37 | Initiates Coverage On | → Buy |
08/24/2021 | 643.49% | Piper Sandler | → $40 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
06/15/2022 | 364.68% | HC Wainwright公司 | → $25 | 開始承保 | →購買 |
05/17/2022 | 178.81% | 摩根士丹利 | $19 → $15 | 維護 | 超重 |
08/24/2021 | — | 考恩公司 | 開始承保 | →跑贏大盤 | |
08/24/2021 | 476.21% | 摩根士丹利 | → $31 | 開始承保 | →超重 |
08/24/2021 | 587.73% | 查爾丹資本 | → $37 | 開始承保 | →購買 |
08/24/2021 | 643.49% | 派珀·桑德勒 | → $40 | 開始承保 | →超重 |
Tenaya Therapeutics Questions & Answers
Tenaya治療公司問答
The latest price target for Tenaya Therapeutics (NASDAQ: TNYA) was reported by HC Wainwright & Co. on June 15, 2022. The analyst firm set a price target for $25.00 expecting TNYA to rise to within 12 months (a possible 364.68% upside). 6 analyst firms have reported ratings in the last year.
Tenaya治療公司(納斯達克代碼:TNYA)的最新目標價是由HC Wainwright&Co.於2022年6月15日報道的。這家分析公司將目標價定為25美元,預計紐約亞幣將在12個月內上漲(可能上漲364.68%)。6家分析公司在過去一年公佈了評級。
The latest analyst rating for Tenaya Therapeutics (NASDAQ: TNYA) was provided by HC Wainwright & Co., and Tenaya Therapeutics initiated their buy rating.
對Tenaya治療公司(納斯達克代碼:TNYA)的最新分析師評級是由HC Wainwright&Co.提供的,Tenaya治療公司啟動了他們的買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on June 15, 2022 so you should expect the next rating to be made available sometime around June 15, 2023.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閲公共財務報表,與Tenaya Treeutics的高管和客户交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Tenaya治療公司的上一次評級是在2022年6月15日提交的,所以你應該預計下一次評級將在2023年6月15日左右的某個時候提供。
While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a initiated with a price target of $0.00 to $25.00. The current price Tenaya Therapeutics (TNYA) is trading at is $5.38, which is within the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Tenaya Treeutics(TNYA)評級是以0.00美元至25.00美元的目標價啟動的。Tenaya治療公司(TNYA)目前的交易價格為5.38美元,在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧